Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796512 | 12579651 | 2 | F | 20160525 | 20160801 | 20160721 | 20160808 | EXP | US-ELI_LILLY_AND_COMPANY-US201606001206 | ELI LILLY AND CO | 55.00 | YR | F | Y | 72.50000 | KG | 20160808 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796512 | 12579651 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK, UNKNOWN | Y | U | 21368 | TABLET | |||||||
| 125796512 | 12579651 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 125796512 | 12579651 | 3 | SS | AMBRISENTAN | AMBRISENTAN | 1 | 0 | TABLET | |||||||||||
| 125796512 | 12579651 | 4 | SS | UPTRAVI | SELEXIPAG | 1 | Unknown | 800 UG, UNKNOWN | U | U | 0 | 800 | UG | ||||||
| 125796512 | 12579651 | 5 | C | LASIX | FUROSEMIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125796512 | 12579651 | 6 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125796512 | 12579651 | 7 | C | KALEXATE | SODIUM POLYSTYRENE SULFONATE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125796512 | 12579651 | 8 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125796512 | 12579651 | 9 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125796512 | 12579651 | 10 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 125796512 | 12579651 | 11 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 0 | ||||||||||||
| 125796512 | 12579651 | 12 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 125796512 | 12579651 | 13 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 125796512 | 12579651 | 14 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125796512 | 12579651 | 15 | C | K-DUR | POTASSIUM CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125796512 | 12579651 | 1 | Product used for unknown indication |
| 125796512 | 12579651 | 2 | Pulmonary hypertension |
| 125796512 | 12579651 | 3 | Hereditary haemorrhagic telangiectasia |
| 125796512 | 12579651 | 4 | Pulmonary hypertension |
| 125796512 | 12579651 | 5 | Product used for unknown indication |
| 125796512 | 12579651 | 6 | Product used for unknown indication |
| 125796512 | 12579651 | 7 | Product used for unknown indication |
| 125796512 | 12579651 | 8 | Product used for unknown indication |
| 125796512 | 12579651 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125796512 | 12579651 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125796512 | 12579651 | Coronary artery disease | |
| 125796512 | 12579651 | Headache | |
| 125796512 | 12579651 | Pulmonary arterial hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125796512 | 12579651 | 1 | 20160525 | 0 | ||
| 125796512 | 12579651 | 2 | 20130313 | 0 | ||
| 125796512 | 12579651 | 4 | 20160614 | 0 |